Compugen Ltd (CGEN) KPIs and segments

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30

$2.10−0.02 (-0.94%)

Close on Nov 13, 2026Market cap $198.56MP/E 5.5Yield –

KPIs & segments

Operating metrics and segments that drive Compugen's business

Coming soon

This tab will track the numbers specific to Compugen's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?